Lead Product(s): ChAdOx1
Therapeutic Area: Infections and Infectious Diseases
Highest Development Status: Phase I Product Type: Vaccine
Partner/Sponsor/Collaborator: The Jenner Institute, Oxford University
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement February 11, 2020
The Jenner Institute at the University of Oxford has agreed a contract with Advent Srl, to produce the first batch of the novel coronavirus vaccine ChAdOx1 nCoV-19 for clinical testing.